Non-familial primary hyperparathyroidism

Seminars in Surgical Oncology

Volumn 13, Issue 2, 1997, Pages 104-113

  Åkerström, Göran ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

hypercalcemia; parathyroid glands pathology; parathyroid hormones; primary hyperparathyroidism genetics pathophysiology diagnosis

Indexed keywords

PARATHYROID HORMONE;

ARTICLE; CALCIUM METABOLISM; CALCIUM STONE; CLINICAL FEATURE; HUMAN; HYPERCALCEMIA; NEPHROLITHIASIS; PARATHYROID HORMONE RELEASE; PATHOPHYSIOLOGY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

BONE DISEASES; CARDIOVASCULAR DISEASES; GASTROINTESTINAL DISEASES; HUMANS; HYPERPARATHYROIDISM; KIDNEY DISEASES; MENTAL DISORDERS; NEUROMUSCULAR DISEASES;

EID: 0030977807     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199703/04)13:2<104::AID-SSU6>3.0.CO;2-D     Document Type: Article

References (40)

1. Palmer M, Ljunghall S, Akerstrom G, et al: Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings. J Chron Dis 1987;40:121-130.
2. Palmer M, Jakobsson S, Akerstrom G, Ljunghall S: Prevalence of hypercalcemia in a health survey: a 14-year follow-up of serum calcium values. [Review] Eur J Clin Invest 1988;18:38-46.
3. NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus development conference statement. [Review] Ann Intern Med 1991;114:593-597.
4. Tisell LE, Hansson G, Lindberg S, Ragnhult I: Hyperparathyroidism in persons treated with X-rays for tuberculous cervical adenitis. Cancer 1977;40:846-854.
5. Akerstrom G, Rudberg C, Grimelius L, et al: Histologic parathyroid abnormalities in an autopsy series. Hum Pathol 1986;17:520-527.
6. Kleeman CR, Norris K, Coburn JW: Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient? [Review] Miner Electrolyte Metab 1987;13:305-310.
7. Fujimoto Y, Obara T, Ito Y, et al: Surgical treatment of ten cases of parathyroid carcinoma: importance of an initial en bloc tumor resection. World J Surg 1984;8:392-400.
8. Silver J, Russell J, Sherwood LM: Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 1985;82:4270-4273.
9. 3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tissue Int 1988;43:213-218.
10. Kremer R, Bolivar I, Golzman D, Hendy GN: Influence of calcium and 1,25-dihydroxicholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 1989;125:935-941.
11. LeBoff MS, Shoback D, Brown EM, et al: Regulation of parathyroid hormone release and cytosolic calcium by extracellular calcium in dispersed and cultured bovine and pathological human parathyroid cells. J Clin Invest 1985;75:49-57.
12. Wallfelt C, Gylfe E, Larsson R, et al: Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism. J Endocrinol 1988;16:457-464.
13. Wallfelt CH, Larsson R, Gylfe E, et al: Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation. World J Surg 1988;12.431-438.
14. Gylfe E, Larsson R, Johansson H, et al: Calcium-activated calcium permeability in parathyroid cells. FEBS Lett 1986;205:132-136.
15. Juhlin C, Holmdahl R, Johansson H, et al: Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. Proc Natl Acad Sci USA 1987;84:2990-2994.
16. Lundgren S, Hjalm G, Hellman P, et al: A protein involved in calcium sensing of the human parathyroid and placental cytotrophoblast belongs to the LDL-receptor protein superfamily. Exp Cell Res 1994;212:344-350.
17. 2+-binding receptor with potential intracellular signaling properties. Eur J Biochem 1996;239:132-137.
18. Juhlin C, Rastad J, Klareskog L, et al: Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells. Am J Pathol 1989;135:321-328.
19. 2+-sensing receptor from bovine parathyroid. Nature 1993;366:575-580.
20. Brown EM, Vassilev PM, Hebert SC: Calcium ions as extracellular messengers. [Review] Cell 1995;83:679-682.
21. 2+ sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996;81:1598-1606
22. Arnold A, Staunton CE, Kim HG, et al: Monoclonality and abnormal parathyroid hormone gene in parathyroid adenomas. N Eng J Med 1988;318:658-662.
23. Arnold A, Brown MF, Urena P, et al: Monoclonality of parathyroid rumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995;95:2047-2053.
24. Loda M, Lipman J, Cukor B, et al: Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity. Hum Pathol 1994,25:1050-1056.
25. Arnold A: Genetic basis of endocrine disease 5. Molecular genetics of parathyroid gland neoplasia. [Review] J Clin Endocrinol Metab 1993;77:1108-1112.
26. Arnold A, Kim HG, Gaz RD, et al: Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989;83.2034-2040.
27. Larsson C, Skogseid B, Oberg K, et al: Multiple endocrine neoplasia type I gene maps to chromosome 11 and is lost in insulinoma. Nature 1988;332(6159):85-87.
28. Friedman E, De Marco L, Gejman PV, et al: Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res 1992;52:6804-6809.
29. Kimura T, Yoshimoto K, Tanaka C, et al. Obvious mRNA and protein expression but absence of mutations of the RET protooncogene in parathyroid tumors. Eur J Endocrinol 1996; 134:314-319.
30. Calendar A, Cougard P: Primary hyperparathyroidism: genetic heterogeneity suggesting different pathogenesis in sporadic and familial forms of parathyroid hyperplasia and tumors. [Review] Eur J Endocrinol 1996;134:263-266.
31. Cryns VL, Thor A, Xu HJ, et al: Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Eng J Med 1994;330:757-761
32. Pearce SH, Trump D, Wooding C, et al: Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours. Clin Endocrinol 1996,45:195-200
33. Cryns VL, Rubio MP, Thor AD, et al: p53 abnormalities m human parathyroid carcinoma. J Clin Endocrinol Metab 1994;78:1320-1324.
34. Cryns VL, Yi SM, Tahara H, et al: Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. [Review] Genes Chromosom Cancer 1995;13:9-17.
35. Tahara H, Smith AP, Gaz RD, et al: Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 1996;56:599-605.
36. Hustmyer FG, Peacock M, Hui S, et al: Bone mineral density in relation to polymorphism at the vitamin D receptor locus J Clin Invest 1994;94:2130-2134.
37. Carling T, Kindmark A, Hellman P, et al: Vitamin D receptor genotypes in primary hyperparathyroidism. Nature Medicine 1995;12:1309-1311.
38. Akerstrom G (ed): "Current Controversy in Parathyroid Operation and Reoperation." Austin, TX: R.G. Landes Company, 1994.
39. Palmer M, Adami HO, Bergstrom R, et al: Survival and renal function in persons with untreated hypercalcemia. Population-based cohort study with 14 years of follow-up. Lancet 1987;1(8524):59-62.
40. Hedback G, Oden A, Tisell LE: The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 1991;15:399-407.